Myocardial perfusion abnormalities in chemical warfare patients intoxicated with mustard gas
Mustard agents are of the major chemical agents used during Iran–Iraq war. There are no reports concerning long-term cardiac effects. The aim was to assess the scintigraphic pattern of myocardial perfusion in patients intoxicated with blistering gases.
We analyzed myocardial perfusion scans of 22 consecutive intoxicated patients (21 male and 1 female, all < 44 years) and compared results with 14 controls. Only those patients and controls were entered whose 10-year risk of coronary artery disease (Framingham criteria) was <5%. Also only those patients were experimented upon that had currently other confirmed complications of intoxication (respiratory, cutaneous and ocular complications). All patients underwent a 1-day stress and rest protocol using 99mTc-MIBI. Images were assessed visually and quantitatively using Cedars Sinai program.
The prevalence of nonhomogeneity of uptake and left and right ventricular enlargement in both visual and quantitative analyses were higher in the mustard exposed patients than unexposed controls. The prevalence of ischemia was higher in the exposed patients (P < 0.05). Cavity to myocardium ratio, as an established and validated measure of ejection fraction, was also significantly lower in the warfare patients than the controls.
In so far it lies in our knowledge, this is the first report concerning the scintigraphic pattern of myocardial perfusion in mustard intoxicated patients. Based on the results, the pattern of myocardial perfusion in these patients is significantly different from normal controls, which could resemble either coronary artery disease or mild cardiomyopathic changes.
KeywordsMyocardial perfusion scintigraphy 99mTc-sestamibi Chemical warfare Mustard agents
Unable to display preview. Download preview PDF.
We are indebted to Dr. Armaghan Fard-Esfahani, Dr. Davood Beiki, Dr. Babak FallahiSichani, and Dr. Mohammad Eftekhari, (Research Institute for Nuclear Medicine, Shariati Hospital) for their consultations throughout the investigation and their suggestions. Thanks are also extended to the technologists at our institute (especially Mr. Hajami, Mr. Derakhshandeh, and Ms. Abedi) for data acquisition.
- 2.U.S Army Field Manual 3–9, U.S. Navy Publication P-467, U.S. Air Force Manual 355–7, “Potential Military Chemical/Biological Agents and Compounds,” Washington DC; 1990Google Scholar
- 3.Federation of American Scientists Report: “Special Weapons Primer.” October 21, 1998. Adapted from Chemical Weapons Technology Militarily Critical Technologies list (MCTL) Part II: Weapons of Mass Destruction Technologies. From: FM 8–9, NATO Handbook on the Medical Aspects of NBC Defensive of the Army, the Navy and Air Force, Washington DC; 1996Google Scholar
- 4.United Nation official reports S/16433(1984), S/17911(1986), and S/18852(1987)Google Scholar
- 5.Statistic Annals Booklet of the Janbazan Organization (2000) Clinical status of chemical warfare victims. Janbazan Organization, Health and Treatment DepartmentGoogle Scholar
- 6.Forootan A (1996) Medical notes on the chemical warfare: Part I. Kowsar Med J 1:91–97Google Scholar
- 10.Easton DF, Peto J, Doll R (1988) Cancers of the respiratory tract in mustard gas workers. Br J Indust Med 45:652–659Google Scholar
- 13.Nishimoto Y, Yamakido M, Shigenobu T et al (1983) Long-term observation of poison gas workers with special reference to respiratory cancers. J UOEH 20(suppl):89–94Google Scholar
- 14.Manning KP, Skegg DC, Stell PM et al (1981) Cancer of the larynx and other occupational hazards of mustard gas workers. Clin Otolaryngol 63:165–170Google Scholar
- 19.Balali M (1984) Clinical and laboratory findings in Iranian fighters with chemical gas poisoning. Arch Belg Suppl:254–259Google Scholar
- 27.Smith KJ, Hurst CG, Moeller RB et al (1995) Sulfur mustard: its continuing threat as a chemical warfare agent, the cutaneous lesions induced, progress in understanding its mechanism of action, its long-term health effects, and new developments for protection and therapy. J Am Acad Dermatol 32:765–776PubMedCrossRefGoogle Scholar
- 28.Ghanei M (2001) Late Pulmonary Complications of Mustard Gas Inhalation. Abstract B2, World Congress on Chemical and Biological Terrorism; Dubrovnic, Croatia; April 23–27Google Scholar
- 29.Aslani J, Ghanei M (1998) A case of unilateral lung collapse in a mustard gas victim. Mil Med 1:49–50Google Scholar
- 40.Roberti RR, Van Tosh A, Baruchin MA et al (1994) Left ventricular cavity-to-myocardial count ratio: a new parameter for detecting resting left ventricular dysfunction directly from tomographic thallium perfusion scintigraphy. J Nucl Med 34:193–198Google Scholar
- 41.Saidova MA, Ostroumov EN, Naumov VG, Sergienko VB, Belenkov IuN (1992) The radionuclide diagnosis of dilated cardiomyopathy: a new approach to assessing myocardial perfusion function by 201Tl scintigraphic data at rest and during the performance of the dipyridamole test. Kardiologiia 32(7–8):50–55PubMedGoogle Scholar
- 46.Ding HJ, Lin CC, Wang JJ, Ho ST, Kao A (2002) Correlation of abnormal response of left ventricular ejection fraction after exercise and left ventricular cavity-to-myocardium count ratio of technetium-99 m-tetrofosmin single photon emission computed tomography in patients with coronary artery disease. Jpn Heart J 43(5):505–514PubMedCrossRefGoogle Scholar